Profuse says the €2.4m grant will be used to get regulatory approval for its small molecule-based cocktail that catalyzes muscle tissue growth for cultivated meat production.
There was much buzz around the world’s first regulatory approval for the sale of cultivated beef, which was granted in Israel early last year. Cultivated meat, which is made from animal cells grown in a lab, has been gaining traction, but the high costs and lengthy production process remain key obstacles to bringing a whole cut of meat to diners.
An Israeli foodtech startup recently received funding from the European Union to seek regulatory approval for technology that it says can help cultivated meat startups produce more meat in a shorter time period, thereby cutting the cost of production by some 50 percent.
Profuse Technology was awarded a 2.4 million euro grant from the EU’s competitive Horizon EIC Transition program to refine its technology, which it says speeds up the time it takes to grow muscle tissue for cultivated meat by 80% while simultaneously improving its nutritional quality, texture, and taste.
“Producing cultivated meat is a big challenge and the industry is in its early days,” Profuse CEO Guy Nevo Michrowski told The Times of Israel. “We don’t solve all the problems, but we provide a piece of the solution needed to eventually be able to grow and produce chunks of steak on a large scale.”
To read the full article click on the link below:
Israel startup gets EU backing to help bring lab-grown meat cuts to table